While its formulation appeals to plant-based diet enthusiasts and those seeking convenience, the proprietary blend and lack of long-term research invite caution
Lancet (London, England), 402 (10403), 693704
My takeaway The oral obesity race is rapidly evolving from who loses the most weight to who patients can stay on the longest. As multiple oral GLP-1 therapies converge around similar efficacy, long-term tolerability, convenience, and real-world persistence are becoming the key commercial battleground
Any medical term is explained in plain language, and if a dose looks off, it's flagged so you can check
Zhao M, Zhao L, Xiong X, He Y, Huang W, Liu Z, et al
Your consultation is the first step toward renewed vitality, and it all starts with a quick call.